VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

rVEE-HA(H1N1)
Vaccine Information
  • Vaccine Name: rVEE-HA(H1N1)
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Vaccine Ontology ID: VO_0004784
  • Type: Recombinant vector vaccine
  • Status: Research
  • Host Species for Licensed Use: Baboon
  • HA gene engineering:
    • Type: Recombinant vector construction
    • Description: The HA gene was transferred into the VEE vector (Davis et al., 1996).
    • Detailed Gene Information: Click Here.
  • Vector:
  • Preparation: (Davis et al., 1996) a VEE vector containing the complete influenza virus hemagglutinin (HA) gene of H1N1 influenza virus.
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Mouse Response

  • Vaccination Protocol: Mice were immunized by subcutaneous inoculation of 10^4 PFU of vector without insert or HA vector in a 10-µl volume of diluent into each rear footpad (Davis et al., 1996).
  • Vaccine Immune Response Type: VO_0003057
  • Challenge Protocol: Immunized mice were challenged intranasally with a virulent strain of influenza virus (Davis et al., 1996).
  • Efficacy: For the immunized mice, replication of challenge virus in their lungs was restricted, and they were completely protected from signs of disease (Davis et al., 1996).
References
Davis et al., 1996: Davis NL, Brown KW, Johnston RE. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. Journal of virology. 1996; 70(6); 3781-3787. [PubMed: 8648713].